Kromann, Charles B <br/><br/>
Does switching from oral to subcutaneous administration of methotrexate influence on patient reported gastro-intestinal adverse effects?  [electronic resource] 

 -  The Journal of dermatological treatment  Apr 2015 
 - 188-90 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1471-1753 
<br/><br/><label>Standard No.: </label>10.3109/09546634.2014.927817  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Antirheumatic Agents--administration & dosage<br/>Humans<br/>Injections, Intramuscular<br/>Injections, Subcutaneous<br/>Methotrexate--administration & dosage<br/>Retrospective Studies<br/>Surveys and Questionnaires